Skip to main content

Published locations for FDA approves HIV-1 treatment ibalizumab for 30-second IV push

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves HIV-1 treatment ibalizumab for 30-second IV push

User login

  • Reset your password
  • /content/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /clinicianreviews/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /familypracticenews/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /idpractitioner/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /internalmedicinenews/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /infectiousdisease/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /internalmedicine/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push
  • /familymedicine/article/258427/hiv/fda-approves-hiv-1-treatment-ibalizumab-30-second-iv-push